Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines
Stroke · 2025-04 · 56 (4) · 1104-1105
DOI: 10.1161/strokeaha.124.049952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke, 2025-04. Verfasst von Adrien Picod und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France (A.P.). Hauptthemen laut MEDLINE: Purpura, Thrombotic Thrombocytopenic, Stroke, Practice Guidelines as Topic, Ischemic Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
The 2024 Guidelines for the Primary Prevention of Stroke, recently updated by the American Heart Association and the American Stroke Association, serve as an essential resource for clinicians aiming to reduce the growing impact of cerebrovascular disease. These guidelines emphasize modifiable risk factors and population-specific considerations, covering a range of cardiovascular conditions, including hypertension, diabetes, atherosclerotic disease, and genetic predispositions to stroke. However, a notable omission in these guidelines is the absence of specific recommendations for patients with thrombotic thrombocytopenic purpura. Indeed, these patients are particularly susceptible to stroke, which can be the sole manifestation of the disease. Given the established association between thrombotic thrombocytopenic purpura and ischemic stroke and the effectiveness of preventive interventions, future guidelines should include specific recommendations for patients with thrombotic thrombocytopenic purpura to avert thrombotic events, including stroke. In that regard, ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) activity measurement should be considered in the workup of cryptogenic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France (A.P.).
- Centre National de Référence des MicroAngiopathies Thrombotiques, Paris, France (A.P., B.S.J., A.V., P.C.).
- Service d'Hématologie Biologique, Laboratoire ADAMTS13, Hôpital Lariboisière, AP-HP Nord, Université Paris Cité, France (B.S.J., A.V.).
- INSERM UMRS 1138, Centre de Recherche des Cordeliers, Paris, France (B.S.J., A.V., P.C.).
- Service d'Hématologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne-Université (AP-HP.6), France (P.C.).
ORCID-Profile: Adrien Picod, Bérangère S Joly
Zitieren
APA
Picod, A., Joly, B. S., Veyradier, A., & Coppo, P. (2025). Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines. Stroke, 56(4), 1104-1105. https://doi.org/10.1161/strokeaha.124.049952
Vancouver
Picod A, Joly BS, Veyradier A, Coppo P. Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines. Stroke. 2025;56(4):1104-1105. doi:10.1161/strokeaha.124.049952
BibTeX
@article{Picod2025,
author = {Picod, Adrien and Joly, Bérangère S and Veyradier, Agnès and Coppo, Paul},
title = {Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention Guidelines},
journal = {Stroke},
year = {2025},
volume = {56},
number = {4},
pages = {1104--1105},
doi = {10.1161/strokeaha.124.049952}
}
EUVIMED